Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-06-28

FDA Approved: USTEKINUMAB-TTWE — Original Application (Quallent Pharmaceuticals Health LLC)

View source ↗

Summary

FDA approves a new biologic product, ustekinumab-tTWE, from Quallent Pharmaceuticals Health LLC, via an Original Biologics License Application. The product is a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • USTEKINUMAB-TTWE (ustekinumab-ttwe)

Snippet

ORIG AP for USTEKINUMAB-TTWE (USTEKINUMAB-TTWE)